References
- Centers for Disease Control and Prevention. Heart failure fact sheet. http://www.cdc.gov/DHDSP/data_statistics/fact_sheets/fs_heart_failure.htm. Accessed April 9, 2012
- Chen MC, Chang HW, Cheng CI, et al. Risk stratification of in-hospital mortality in patients hospitalized for chronic congestive heart failure secondary to non-ischemic cardiomyopathy. Cardiology 2003;100:136-42
- Gheorghiade M, Rossi JS, Cotts W, et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 2007;167:1998-2005
- Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-8
- Romanovsky A, Bagshaw S, Rosner MH. Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy. Intern J Nephrol 2011;2011:732-46
- Lee WH, Packer M. Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 1986;73:257-67
- Shorr AF, Tabak YP, Johannes RS, et al. Burden of sodium abnormalities in patients hospitalized for heart failure. Cong Heart Fail 2011;17:1-7
- Boscoe A, Paramore C, Verbalis JG. Cost of illness of hyponatremia in the United States. Cost Eff Resour Alloc 2006;4:1-11
- Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9
- Nixon RM, Thompson SG. Parametric modeling of cost data in medical studies. Statist Med 2004;23:1311-31
- Wald R, Jaber BL, Price LL, et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010;170:294-302
- Zilberberg MD, Exuzides A, Spalding J, et al. Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin 2008;24:1601-8
- Callahan MA, Do HT, Caplan DW, et al. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med 2009;121:186-91
- Gheorghiade M, Abraham WT, Albert NM, et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 2007;28:980-8
- Dunlay SM, Gheorghiade M, Reid KJ, et al. Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail 2010;12:367-74
- Stranges E, Stocks C. Potentially preventable hospitalizations for acute and chronic conditions, 2008. HCUP Statistical Brief #99. Rockville, MD: Agency for Healthcare Research and Quality, 2010. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb99.jsp. Accessed April 10, 2012
- Stone J, Hoffman, GJ. Medicare hospital readmissions: issues, policy options and PPACA. (R40972). Washington, DC: Congressional Research Service, 2010. http://www.hospitalmedicine.org/AM/pdf/advocacy/CRS_Readmissions_Report.pdf. Accessed May 5, 2012
- Chiong JR, Kim S, Lin J, et al. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial. J Med Econ 2012;15:276-84